A Stock Overview
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Agilent Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$132.44 |
| 52 Week High | US$151.58 |
| 52 Week Low | US$96.80 |
| Beta | 1.12 |
| 1 Month Change | -10.14% |
| 3 Month Change | 0.93% |
| 1 Year Change | -2.28% |
| 3 Year Change | -1.55% |
| 5 Year Change | 72.63% |
| Change since IPO | 209.80% |
Recent News & Updates
These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well
Apr 05
Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold
Mar 12Recent updates
These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well
Apr 05Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold
Mar 12Agilent Technologies Hit A Homerun
Dec 24Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)
Dec 08Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly
Dec 07Agilent Technologies: Looking Undervalued Heading Into Earnings
Nov 17Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Oct 26Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart
Sep 26Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?
Sep 08Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly
Aug 21Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
Jul 23Agilent Technologies - A Wealth Compounder 30% Below Its Highs
Jul 13Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today
Jul 10What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?
May 28Agilent Technologies Stock: Starting To Look Appealing
May 25These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Safely
Apr 17Calculating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Apr 03Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today
Mar 21Agilent Technologies, Inc.'s (NYSE:A) CEO Compensation Is Looking A Bit Stretched At The Moment
Mar 09Agilent Technologies declares $0.225 dividend
Feb 22Fluor's unit gets contract to expand Agilent's manufacturing facility in Colorado
Feb 16Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?
Jan 30Agilent Technologies: A Proven Track Record Of Shareholder Value Creation, Hold
Jan 16Agilent to acquire Avida for cancer research
Jan 04Agilent Technologies (NYSE:A) Has A Rock Solid Balance Sheet
Dec 30Agilent's liquid biopsy test gets FDA nod for companion diagnostic test to Mirati's Krazati
Dec 13Agilent Technologies raises quarterly dividend by 7.1% to $0.225/share
Nov 16Is Agilent Technologies, Inc. (NYSE:A) Worth US$138 Based On Its Intrinsic Value?
Nov 08Why Agilent Technologies, Inc. (NYSE:A) Could Be Worth Watching
Oct 26Here's Why Agilent Technologies (NYSE:A) Has Caught The Eye Of Investors
Oct 02Shareholder Returns
| A | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -8.7% | -5.9% | -3.7% |
| 1Y | -2.3% | -5.5% | 20.2% |
Return vs Industry: A exceeded the US Life Sciences industry which returned -4.3% over the past year.
Return vs Market: A underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| A volatility | |
|---|---|
| A Average Weekly Movement | 3.3% |
| Life Sciences Industry Average Movement | 7.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: A has not had significant price volatility in the past 3 months.
Volatility Over Time: A's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 17,700 | Mike McMullen | www.agilent.com |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Agilent Technologies, Inc. Fundamentals Summary
| A fundamental statistics | |
|---|---|
| Market cap | US$38.81b |
| Earnings (TTM) | US$1.24b |
| Revenue (TTM) | US$6.74b |
31.4x
P/E Ratio5.8x
P/S RatioIs A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A income statement (TTM) | |
|---|---|
| Revenue | US$6.74b |
| Cost of Revenue | US$3.33b |
| Gross Profit | US$3.41b |
| Other Expenses | US$2.17b |
| Earnings | US$1.24b |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.22 |
| Gross Margin | 50.56% |
| Net Profit Margin | 18.35% |
| Debt/Equity Ratio | 41.3% |
How did A perform over the long term?
See historical performance and comparison